Sodium Hydroxide → HCID 66852813, compound
Reaction equation
[C:1]([NH:5][C:6]([C:8]1[CH:9]=[N:10][N:11]2[CH:16]=[CH:15][C:14]([N:17]3[CH2:21][C@H:20]([OH:22])[CH2:19][C@@H:18]3[C:23]3[CH:28]=[CH:27][CH:26]=[C:25]([F:29])[CH:24]=3)=[N:13][C:12]=12)=[O:7])([CH3:4])([CH3:3])[CH3:2].CC(OI1(OC(C)=O)(OC(C)=O)OC(=O)C2C=CC=CC1=2)=O.[OH-].[Na+]>C(Cl)Cl.[Cl-].[Na+].O>[C:1]([NH:5][C:6]([C:8]1[CH:9]=[N:10][N:11]2[CH:16]=[CH:15][C:14]([N:17]3[CH2:21][C:20](=[O:22])[CH2:19][C@@H:18]3[C:23]3[CH:28]=[CH:27][CH:26]=[C:25]([F:29])[CH:24]=3)=[N:13][C:12]=12)=[O:7])([CH3:4])([CH3:2])[CH3:3]Participants
6
Procedure
N-tert-butyl-5-((2R,4R)-2-(3-fluorophenyl)-4-hydroxypyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide (Example 42, 10 mg, 0.025 mmol) and the Dess-Martin reagent (16 mg, 0.038 mmol) in DCM (2.0 mL) were stirred at ambient temperature overnight. 1N NaOH (2.5 mL) was added and the reaction stirred for 30 minutes. Brine (2.5 mL) was added and the reaction was filtered through a phase separator frit, washing with several portions of DCM. The DCM solution was concentrated and the residue purified by reverse phase chromatography (20-70% acetonitrile/water) to provide the title compound (2.7 mg, 27% yield) as a clear oil. MS (apci) m/z=396.0 (M+H).
Workup
- filtrationthe reaction was filtered through a phase separator frit
- washwashing with several portions of DCM
- concentrationThe DCM solution was concentrated
- customthe residue purified by reverse phase chromatography (20-70% acetonitrile/water)
Sources & evidence
- ORD record
- ord-74ec6e602bea45659f68bc6faa292656
- Source dataset
- uspto-grants-2014_07
- Patent number
- US08791123B2
Reaction notes
Loading…